Home > News > A Rexahn, UMD Partnership
February 9th, 2006
Abstract:
Rexahn Pharmaceuticals Inc., a Rockville biotech company, is partnering with University of Maryland School of Pharmacy's Center for Nanomedicine and Cellular Delivery to develop drugs targeting cancer and central nervous system disorders. (last article on the page)
Source:
washingtonpost.com
Related Links |
Center for Nanomedicine and Cellular Delivery
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||